Analysis of bypass signaling in EGFR pathway and profiling of bypass genes for predicting response to anticancer EGFR tyrosine kinase inhibitors
出版年份 2012 全文链接
标题
Analysis of bypass signaling in EGFR pathway and profiling of bypass genes for predicting response to anticancer EGFR tyrosine kinase inhibitors
作者
关键词
-
出版物
Molecular BioSystems
Volume 8, Issue 10, Pages 2645
出版商
Royal Society of Chemistry (RSC)
发表日期
2012-06-26
DOI
10.1039/c2mb25165e
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Outgrowth of single oncogene-expressing cells from suppressive epithelial environments
- (2012) Cheuk T. Leung et al. NATURE
- Molecular Characteristics Predict Clinical Outcomes: Prospective Trial Correlating Response to the EGFR Tyrosine Kinase Inhibitor Gefitinib with the Presence of Sensitizing Mutations in the Tyrosine Binding Domain of the EGFR Gene
- (2011) N. A. Rizvi et al. CLINICAL CANCER RESEARCH
- Increased Detection Sensitivity for KRAS Mutations Enhances the Prediction of Anti-EGFR Monoclonal Antibody Resistance in Metastatic Colorectal Cancer
- (2011) F. Molinari et al. CLINICAL CANCER RESEARCH
- A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer
- (2011) Christos Hatzis JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data
- (2011) Angelo Di Leo et al. LANCET ONCOLOGY
- Combined VEGF-A and VEGFR-2 concentrations in plasma: Diagnostic and prognostic implications in patients with advanced NSCLC
- (2011) Eloisa Jantus-Lewintre et al. LUNG CANCER
- The Tissue Microlocalisation and Cellular Expression of CD163, VEGF, HLA-DR, iNOS, and MRP 8/14 Is Correlated to Clinical Outcome in NSCLC
- (2011) Chandra M. Ohri et al. PLoS One
- The Influence of Feature Selection Methods on Accuracy, Stability and Interpretability of Molecular Signatures
- (2011) Anne-Claire Haury et al. PLoS One
- Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance
- (2011) J.-P. Gillet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
- (2011) L. V. Sequist et al. Science Translational Medicine
- A Multicenter Phase II Clinical Trial of Lapatinib (GW572016) in Hormonally Untreated Advanced Prostate Cancer
- (2010) Srikala S. Sridhar et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Cyclooxygenase-2 in tumorigenesis of gastrointestinal cancers: An update on the molecular mechanisms
- (2010) William Ka Kei Wu et al. CANCER LETTERS
- MET and KRAS Gene Amplification Mediates Acquired Resistance to MET Tyrosine Kinase Inhibitors
- (2010) V. Cepero et al. CANCER RESEARCH
- Targeting Multiple Kinase Pathways: A Change In Paradigm
- (2010) L. Gossage et al. CLINICAL CANCER RESEARCH
- DNA Microarrays Are Predictive of Cancer Prognosis: A Re-evaluation
- (2010) X. Fan et al. CLINICAL CANCER RESEARCH
- ERBB2 and TOP2A in Breast Cancer: A Comprehensive Analysis of Gene Amplification, RNA Levels, and Protein Expression and Their Influence on Prognosis and Prediction
- (2010) J. C. Brase et al. CLINICAL CANCER RESEARCH
- Evaluation of a 30-Gene Paclitaxel, Fluorouracil, Doxorubicin, and Cyclophosphamide Chemotherapy Response Predictor in a Multicenter Randomized Trial in Breast Cancer
- (2010) A. Tabchy et al. CLINICAL CANCER RESEARCH
- Randomized Phase II Multicenter Trial of Two Schedules of Lapatinib as First- or Second-Line Monotherapy in Patients with Advanced or Metastatic Non-Small Cell Lung Cancer
- (2010) H. J. Ross et al. CLINICAL CANCER RESEARCH
- Predictive Molecular Markers of Response to Epidermal Growth Factor Receptor(EGFR) Family-Targeted Therapies
- (2010) Sarah Barton et al. CURRENT CANCER DRUG TARGETS
- Gene expression profiling reveals novel biomarkers in nonsmall cell lung cancer
- (2010) Abel Sanchez-Palencia et al. INTERNATIONAL JOURNAL OF CANCER
- Personalized Medicine in Non–Small-Cell Lung Cancer: IsKRASa Useful Marker in Selecting Patients for Epidermal Growth Factor Receptor–Targeted Therapy?
- (2010) Patrick J. Roberts et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy
- (2010) J Rafael Sierra et al. Molecular Cancer
- Understanding resistance to EGFR inhibitors—impact on future treatment strategies
- (2010) Deric L. Wheeler et al. Nature Reviews Clinical Oncology
- Integrating molecular diagnostics into anticancer drug discovery
- (2010) István Peták et al. NATURE REVIEWS DRUG DISCOVERY
- NCBI GEO: archive for functional genomics data sets--10 years on
- (2010) T. Barrett et al. NUCLEIC ACIDS RESEARCH
- COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
- (2010) S. A. Forbes et al. NUCLEIC ACIDS RESEARCH
- Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitor
- (2010) D Ercan et al. ONCOGENE
- The Tumor Microenvironment in Non–Small-Cell Lung Cancer
- (2010) Edward E. Graves et al. SEMINARS IN RADIATION ONCOLOGY
- Robust biomarker identification for cancer diagnosis with ensemble feature selection methods
- (2009) Thomas Abeel et al. BIOINFORMATICS
- Response to gefitinib and erlotinib in Non-small cell lung cancer: a retrospective study
- (2009) Ivette F Emery et al. BMC CANCER
- HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment
- (2009) Britta Weigelt et al. BREAST CANCER RESEARCH AND TREATMENT
- Gene expression profile and response to trastuzumab–docetaxel-based treatment in breast carcinoma
- (2009) F Végran et al. BRITISH JOURNAL OF CANCER
- Association of constitutively activated hepatocyte growth factor receptor (Met) with resistance to a dual EGFR/Her2 inhibitor in non-small-cell lung cancer cells
- (2009) S Agarwal et al. BRITISH JOURNAL OF CANCER
- Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer
- (2009) Enrique Carrillo de Santa Pau et al. CANCER
- Prediction of Clinical Outcome in Multiple Lung Cancer Cohorts by Integrative Genomics: Implications for Chemotherapy Selection
- (2009) P. Broet et al. CANCER RESEARCH
- PIK3CA Mutations in Colorectal Cancer Are Associated with Clinical Resistance to EGFR-Targeted Monoclonal Antibodies
- (2009) A. Sartore-Bianchi et al. CANCER RESEARCH
- Substrate-dependent bidirectional modulation of P-glycoprotein-mediated drug resistance by erlotinib
- (2009) Kohji Noguchi et al. CANCER SCIENCE
- ABC Efflux Pump-Based Resistance to Chemotherapy Drugs
- (2009) Paul D. W. Eckford et al. CHEMICAL REVIEWS
- Mammary-Derived Growth Inhibitor Alters Traffic of EGFR and Induces a Novel Form of Cetuximab Resistance
- (2009) J. Nevo et al. CLINICAL CANCER RESEARCH
- Combined Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor (EGFR) Blockade Inhibits Tumor Growth in Xenograft Models of EGFR Inhibitor Resistance
- (2009) G. N. Naumov et al. CLINICAL CANCER RESEARCH
- Mutations and Response to Epidermal Growth Factor Receptor Inhibitors
- (2009) P. Laurent-Puig et al. CLINICAL CANCER RESEARCH
- A Multi-Institutional Phase II Study of the Efficacy and Tolerability of Lapatinib in Patients with Advanced Hepatocellular Carcinomas
- (2009) T. Bekaii-Saab et al. CLINICAL CANCER RESEARCH
- EGFR-directed therapies to treat non-small-cell lung cancer
- (2009) Cheryl Ho et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Predicting drug susceptibility of non–small cell lung cancers based on genetic lesions
- (2009) Martin L. Sos et al. JOURNAL OF CLINICAL INVESTIGATION
- Analysis of PTEN, BRAF, and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer
- (2009) Pierre Laurent-Puig et al. JOURNAL OF CLINICAL ONCOLOGY
- Vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 expression in non-small cell lung cancer patients: Relation to prognosis
- (2009) Barbara Bonnesen et al. LUNG CANCER
- Predictors of gefitinib outcomes in advanced non-small cell lung cancer (NSCLC): Study of a comprehensive panel of molecular markers
- (2009) Marcello Tiseo et al. LUNG CANCER
- Cyclooxygenase-2 (COX-2) Negatively Regulates Expression of Epidermal Growth Factor Receptor and Causes Resistance to Gefitinib in COX-2-Overexpressing Cancer Cells
- (2009) Y. M. Kim et al. MOLECULAR CANCER RESEARCH
- Novel mutant-selective EGFR kinase inhibitors against EGFR T790M
- (2009) Wenjun Zhou et al. NATURE
- A crowdsourcing evaluation of the NIH chemical probes
- (2009) Tudor I Oprea et al. Nature Chemical Biology
- Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC
- (2009) Helena Linardou et al. Nature Reviews Clinical Oncology
- Mechanisms of drug combinations: interaction and network perspectives
- (2009) Jia Jia et al. NATURE REVIEWS DRUG DISCOVERY
- Microarrays and high-throughput transcriptomic analysis in species with incomplete availability of genomic sequences
- (2009) Lorraine Pariset et al. New Biotechnology
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
- (2009) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overview of molecular testing in non-small-cell lung cancer: mutational analysis, gene copy number, protein expression and other biomarkers of EGFR for the prediction of response to tyrosine kinase inhibitors
- (2009) T John et al. ONCOGENE
- Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors
- (2009) A F Gazdar ONCOGENE
- Alterations in Genes of the EGFR Signaling Pathway and Their Relationship to EGFR Tyrosine Kinase Inhibitor Sensitivity in Lung Cancer Cell Lines
- (2009) Jeet Gandhi et al. PLoS One
- Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia
- (2009) R. T. Calado et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The ERBB3 receptor in cancer and cancer gene therapy
- (2008) G Sithanandam et al. CANCER GENE THERAPY
- Elevated CRAF as a Potential Mechanism of Acquired Resistance to BRAF Inhibition in Melanoma
- (2008) C. Montagut et al. CANCER RESEARCH
- An Integrative Genomic and Proteomic Analysis of PIK3CA, PTEN, and AKT Mutations in Breast Cancer
- (2008) K. Stemke-Hale et al. CANCER RESEARCH
- Kinase switching in mesenchymal-like non-small cell lung cancer lines contributes to EGFR inhibitor resistance through pathway redundancy
- (2008) Stuart Thomson et al. CLINICAL & EXPERIMENTAL METASTASIS
- KRAS mutations predict response to EGFR inhibitors
- (2008) Mitch Raponi et al. CURRENT OPINION IN PHARMACOLOGY
- Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer
- (2008) Helena Linardou et al. LANCET ONCOLOGY
- Next-generation DNA sequencing
- (2008) Jay Shendure et al. NATURE BIOTECHNOLOGY
- Systematic assessment of copy number variant detection via genome-wide SNP genotyping
- (2008) Gregory M Cooper et al. NATURE GENETICS
- The Universal Protein Resource (UniProt) 2009
- (2008) NUCLEIC ACIDS RESEARCH
- Cell Line Data Base: structure and recent improvements towards molecular authentication of human cell lines
- (2008) P. Romano et al. NUCLEIC ACIDS RESEARCH
- Comparison of 3D and 2D tumor models reveals enhanced HER2 activation in 3D associated with an increased response to trastuzumab
- (2008) M Pickl et al. ONCOGENE
- HER2 Oncogenic Function Escapes EGFR Tyrosine Kinase Inhibitors via Activation of Alternative HER Receptors in Breast Cancer Cells
- (2008) Anthony Kong et al. PLoS One
- The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP
- (2008) C.-H. Yun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EGFR and β1 integrins utilize different signaling pathways to activate Akt
- (2007) Teet Velling et al. EXPERIMENTAL CELL RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search